Herbert Silver
Hartford Hospital
11 Papers
89 Citations
Herbert Silver is an academic researcher from Hartford Hospital. The author has contributed to research in topics: Hemolysis & Blood transfusion. The author has an hindex of 6, co-authored 11 publications.
Chat about Author
Papers
Universal WBC reduction.
Robert L. Thurer,Naomi L.C. Luban,James P. AuBuchon,Herbert Silver,Leo J. McCarthy,Sunny Dzik,Christopher P. Stowell,S. Breanndan Moore,Eleftherios C. Vamvakas,Will Armstrong,Michael H. Kanter,Elaine Jeter,Joanne Becker,Martha J. Higgins,Susan A. Galel,Steven Kleinman,Carol S. Marshall,Richard S. Newman,Jose A. Ocariz,Douglas P. Blackall,Lawrence D. Petz,Pearl Toy,Harold A. Oberman,Don L. Siegel,Thomas H. Price,Sherrill J. Slichter,Terry B. Gernsheimer,Paul D. Mintz,Lawrence T. Goodnough,Edward H. Lipford,Marcus B. Simpson +30 more
59
The use of microaggregate filtration in the prevention of febrile transfusion reactions.
A R Schned,Herbert Silver +1 more
TL;DR: In both patient populations the microaggregate filtration method proved at least as effective as the inverted spin method and was clearly superior to the buffy coat‐poor method in preventing febrile transfusion reactions.
30
Limitations of paternity testing calculations
Herbert Silver,A Schoppmann +1 more
TL;DR: A total of 252 black and white trios in which the alleged father was known not to be the biological father were generated from paternity studies, and the likelihood of paternity and the paternity index were calculated on the basis of ABO, Rh, MNS, and HLA phenotyping.
8
A simplified method for quality control of deglycerolized erythrocytes.
TL;DR: In contrast to generally held beliefs, the in vivo 24‐hour survival of red blood cells with a residual glycerol concentration of up to 2.7% was demonstrated to be 76% of greater, a level which is well above what is usually accepted as adequate.
7
Adoptive immunotherapy with peripheral blood lymphocytes cocultured in vitro with autologous tumor cells and interleukin-2.
Jonathan R. Sporn,Michael T. Ergin,Gerald R. Robbins,Ritchard G. Cable,Herbert Silver,Bijay Mukherji +5 more
TL;DR: A clinical trial of adoptive immunotherapy was carried out with peripheral blood lymphocytes (PBL), cocultured in vitro with autologous tumor cells and interieukin-2 (IL-2), in 14 patients with advanced melanoma, finding no major therapeutic response was observed.
7